Laura Brown
Concepts (256)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fetal Growth Retardation | 36 | 2025 | 582 | 8.430 |
Why?
| | Placental Insufficiency | 19 | 2025 | 125 | 5.960 |
Why?
| | Fetus | 38 | 2024 | 802 | 5.750 |
Why?
| | Sheep | 56 | 2025 | 874 | 4.980 |
Why?
| | Amino Acids | 21 | 2023 | 497 | 4.950 |
Why?
| | Muscle, Skeletal | 19 | 2025 | 1757 | 3.710 |
Why?
| | Fetal Development | 14 | 2025 | 299 | 3.560 |
Why?
| | Glucose | 26 | 2024 | 1041 | 3.230 |
Why?
| | Insulin | 32 | 2024 | 2491 | 2.410 |
Why?
| | Pregnancy | 63 | 2025 | 7092 | 2.180 |
Why?
| | Insulin-Like Growth Factor I | 6 | 2024 | 325 | 1.920 |
Why?
| | Leucine | 10 | 2022 | 118 | 1.730 |
Why?
| | Myoblasts | 3 | 2021 | 82 | 1.640 |
Why?
| | Liver | 14 | 2024 | 1820 | 1.510 |
Why?
| | Fetal Heart | 2 | 2024 | 56 | 1.380 |
Why?
| | Oxidation-Reduction | 9 | 2024 | 1087 | 1.190 |
Why?
| | Dietary Proteins | 3 | 2023 | 136 | 1.170 |
Why?
| | Infant, Premature | 6 | 2023 | 598 | 1.170 |
Why?
| | Muscle Development | 4 | 2025 | 114 | 1.160 |
Why?
| | Animals | 65 | 2025 | 37748 | 1.160 |
Why?
| | Enteral Nutrition | 2 | 2023 | 202 | 1.080 |
Why?
| | Hyperinsulinism | 6 | 2020 | 122 | 1.030 |
Why?
| | Infant Nutritional Physiological Phenomena | 5 | 2023 | 144 | 1.000 |
Why?
| | Muscle Fibers, Slow-Twitch | 1 | 2025 | 23 | 0.950 |
Why?
| | Cell Proliferation | 5 | 2025 | 2506 | 0.940 |
Why?
| | Citrate (si)-Synthase | 2 | 2024 | 60 | 0.940 |
Why?
| | Muscle Fibers, Skeletal | 3 | 2021 | 216 | 0.910 |
Why?
| | Fetal Weight | 3 | 2022 | 55 | 0.900 |
Why?
| | Capillaries | 1 | 2025 | 124 | 0.890 |
Why?
| | Gestational Age | 12 | 2025 | 959 | 0.850 |
Why?
| | Placenta | 9 | 2024 | 769 | 0.850 |
Why?
| | Hindlimb | 3 | 2021 | 134 | 0.840 |
Why?
| | Female | 68 | 2025 | 75943 | 0.830 |
Why?
| | Mitochondria, Heart | 1 | 2024 | 102 | 0.820 |
Why?
| | Muscle Proteins | 3 | 2022 | 240 | 0.790 |
Why?
| | Maternal-Fetal Exchange | 7 | 2024 | 172 | 0.790 |
Why?
| | Parenteral Nutrition | 1 | 2023 | 105 | 0.770 |
Why?
| | Infant Formula | 3 | 2014 | 73 | 0.770 |
Why?
| | Pancreas | 7 | 2024 | 326 | 0.760 |
Why?
| | Infant, Extremely Premature | 1 | 2023 | 66 | 0.760 |
Why?
| | Myoblasts, Skeletal | 1 | 2021 | 12 | 0.730 |
Why?
| | Hypoxia | 5 | 2021 | 1165 | 0.730 |
Why?
| | Gluconeogenesis | 7 | 2024 | 78 | 0.720 |
Why?
| | Infant, Newborn | 10 | 2023 | 6289 | 0.670 |
Why?
| | Infusions, Intravenous | 6 | 2024 | 417 | 0.660 |
Why?
| | Lactic Acid | 8 | 2024 | 303 | 0.660 |
Why?
| | Disease Models, Animal | 11 | 2025 | 4421 | 0.600 |
Why?
| | Hypoglycemia | 6 | 2015 | 468 | 0.600 |
Why?
| | Myocytes, Cardiac | 2 | 2025 | 536 | 0.590 |
Why?
| | Protein Biosynthesis | 3 | 2017 | 444 | 0.580 |
Why?
| | Ibuprofen | 1 | 2018 | 83 | 0.550 |
Why?
| | Ductus Arteriosus, Patent | 1 | 2018 | 53 | 0.550 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2023 | 1634 | 0.540 |
Why?
| | Hypoglycemic Agents | 3 | 2024 | 1374 | 0.490 |
Why?
| | Islets of Langerhans | 6 | 2024 | 804 | 0.470 |
Why?
| | Sweetening Agents | 1 | 2015 | 56 | 0.460 |
Why?
| | Lower Extremity | 1 | 2019 | 439 | 0.450 |
Why?
| | Mitochondria | 1 | 2021 | 979 | 0.450 |
Why?
| | Cell Division | 1 | 2017 | 798 | 0.450 |
Why?
| | Oxidative Stress | 1 | 2021 | 1334 | 0.450 |
Why?
| | Glucagon | 6 | 2024 | 104 | 0.440 |
Why?
| | Endocrine System | 1 | 2014 | 21 | 0.430 |
Why?
| | Blood Glucose | 12 | 2024 | 2278 | 0.430 |
Why?
| | Fetal Hypoxia | 3 | 2021 | 55 | 0.410 |
Why?
| | Milk, Human | 2 | 2020 | 169 | 0.410 |
Why?
| | Growth | 1 | 2013 | 52 | 0.410 |
Why?
| | Intelligence | 1 | 2013 | 134 | 0.390 |
Why?
| | Dietary Carbohydrates | 2 | 2014 | 153 | 0.380 |
Why?
| | Developmental Disabilities | 1 | 2015 | 284 | 0.380 |
Why?
| | Dietary Supplements | 3 | 2012 | 570 | 0.370 |
Why?
| | Organ Size | 5 | 2021 | 481 | 0.360 |
Why?
| | Oxidative Phosphorylation | 2 | 2024 | 204 | 0.360 |
Why?
| | Fetal Blood | 7 | 2024 | 341 | 0.350 |
Why?
| | Placental Circulation | 2 | 2021 | 71 | 0.340 |
Why?
| | Hepatocytes | 5 | 2024 | 211 | 0.330 |
Why?
| | Glucose Clamp Technique | 4 | 2020 | 197 | 0.320 |
Why?
| | Metformin | 2 | 2024 | 333 | 0.320 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2014 | 663 | 0.310 |
Why?
| | Weight Gain | 1 | 2013 | 539 | 0.310 |
Why?
| | Insulin-Secreting Cells | 4 | 2024 | 382 | 0.310 |
Why?
| | Mannose | 1 | 2009 | 24 | 0.310 |
Why?
| | Inositol | 1 | 2009 | 25 | 0.310 |
Why?
| | Body Weight | 1 | 2013 | 997 | 0.300 |
Why?
| | Sugar Alcohols | 1 | 2008 | 3 | 0.290 |
Why?
| | Carbohydrates | 1 | 2008 | 68 | 0.280 |
Why?
| | Energy Metabolism | 3 | 2021 | 932 | 0.280 |
Why?
| | Postprandial Period | 1 | 2008 | 111 | 0.270 |
Why?
| | Milk | 1 | 2008 | 123 | 0.270 |
Why?
| | Random Allocation | 5 | 2012 | 367 | 0.270 |
Why?
| | Drug Administration Schedule | 4 | 2021 | 771 | 0.270 |
Why?
| | Pyruvic Acid | 2 | 2024 | 55 | 0.250 |
Why?
| | Oxygen | 6 | 2023 | 992 | 0.250 |
Why?
| | Proteins | 1 | 2012 | 1015 | 0.240 |
Why?
| | Ploidies | 1 | 2025 | 19 | 0.240 |
Why?
| | Glucagon-Secreting Cells | 2 | 2024 | 23 | 0.240 |
Why?
| | Livestock | 1 | 2025 | 11 | 0.240 |
Why?
| | Lipid Metabolism | 3 | 2024 | 528 | 0.230 |
Why?
| | Up-Regulation | 4 | 2017 | 860 | 0.230 |
Why?
| | Heat-Shock Response | 1 | 2025 | 77 | 0.220 |
Why?
| | Heat Stress Disorders | 1 | 2025 | 82 | 0.210 |
Why?
| | Infant, Small for Gestational Age | 2 | 2022 | 104 | 0.210 |
Why?
| | Cell Respiration | 1 | 2024 | 106 | 0.210 |
Why?
| | Oxygen Consumption | 2 | 2024 | 715 | 0.200 |
Why?
| | Humans | 21 | 2025 | 141749 | 0.200 |
Why?
| | Amines | 1 | 2023 | 43 | 0.200 |
Why?
| | Adaptation, Physiological | 2 | 2021 | 562 | 0.200 |
Why?
| | Ultrasonography, Prenatal | 2 | 2022 | 291 | 0.190 |
Why?
| | Cell Cycle | 1 | 2025 | 600 | 0.190 |
Why?
| | Blotting, Western | 4 | 2019 | 1234 | 0.180 |
Why?
| | Cystathionine gamma-Lyase | 1 | 2020 | 13 | 0.170 |
Why?
| | Placentation | 1 | 2021 | 46 | 0.170 |
Why?
| | Dairy Products | 1 | 2021 | 30 | 0.170 |
Why?
| | Phosphoenolpyruvate Carboxykinase (ATP) | 2 | 2012 | 14 | 0.160 |
Why?
| | Hydrogen Sulfide | 1 | 2020 | 45 | 0.160 |
Why?
| | Meat | 1 | 2021 | 93 | 0.160 |
Why?
| | Bromodeoxyuridine | 1 | 2019 | 80 | 0.160 |
Why?
| | Amino Acid Transport Systems | 1 | 2020 | 42 | 0.160 |
Why?
| | Body Composition | 2 | 2022 | 703 | 0.160 |
Why?
| | Insulin Resistance | 4 | 2019 | 1225 | 0.160 |
Why?
| | Pregnancy, Animal | 1 | 2019 | 52 | 0.160 |
Why?
| | Blood Gas Analysis | 2 | 2012 | 82 | 0.150 |
Why?
| | Adipose Tissue | 2 | 2021 | 647 | 0.150 |
Why?
| | Gynecology | 1 | 2021 | 179 | 0.150 |
Why?
| | Adenosine Triphosphatases | 1 | 2020 | 159 | 0.150 |
Why?
| | Amino Acids, Branched-Chain | 4 | 2021 | 36 | 0.150 |
Why?
| | Sodium | 1 | 2020 | 196 | 0.150 |
Why?
| | Alanine | 1 | 2019 | 158 | 0.150 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 2 | 2016 | 30 | 0.140 |
Why?
| | Glucose-6-Phosphatase | 3 | 2016 | 33 | 0.140 |
Why?
| | Point-of-Care Systems | 1 | 2020 | 188 | 0.140 |
Why?
| | Indomethacin | 1 | 2018 | 87 | 0.140 |
Why?
| | Anemia | 2 | 2017 | 177 | 0.140 |
Why?
| | RNA, Messenger | 4 | 2016 | 2828 | 0.140 |
Why?
| | Protein Kinases | 2 | 2009 | 308 | 0.130 |
Why?
| | Temperature | 1 | 2019 | 669 | 0.130 |
Why?
| | Male | 9 | 2021 | 70179 | 0.130 |
Why?
| | Infusion Pumps | 2 | 2021 | 34 | 0.120 |
Why?
| | Kinetics | 2 | 2012 | 1655 | 0.120 |
Why?
| | Acetaminophen | 1 | 2018 | 264 | 0.120 |
Why?
| | Lactates | 1 | 2015 | 85 | 0.120 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2024 | 2537 | 0.120 |
Why?
| | Metabolomics | 1 | 2021 | 704 | 0.110 |
Why?
| | Infant | 4 | 2023 | 9843 | 0.110 |
Why?
| | Breast Feeding | 2 | 2009 | 444 | 0.110 |
Why?
| | Endocrine System Diseases | 1 | 2014 | 35 | 0.110 |
Why?
| | Gene Expression Regulation | 4 | 2020 | 2608 | 0.110 |
Why?
| | In Vitro Techniques | 1 | 2016 | 1094 | 0.110 |
Why?
| | Hydrops Fetalis | 1 | 2014 | 13 | 0.110 |
Why?
| | Nutritional Requirements | 1 | 2014 | 81 | 0.100 |
Why?
| | Hemangioma | 1 | 2014 | 45 | 0.100 |
Why?
| | Pregnancy Complications | 1 | 2019 | 587 | 0.100 |
Why?
| | Time Factors | 4 | 2012 | 6966 | 0.100 |
Why?
| | Arginine | 2 | 2012 | 260 | 0.100 |
Why?
| | Diet | 1 | 2021 | 1282 | 0.100 |
Why?
| | Food | 1 | 2014 | 163 | 0.100 |
Why?
| | Carbon Dioxide | 2 | 2012 | 241 | 0.100 |
Why?
| | Algorithms | 3 | 2014 | 1768 | 0.100 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2017 | 2064 | 0.090 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2014 | 389 | 0.090 |
Why?
| | Acid-Base Equilibrium | 1 | 2012 | 24 | 0.090 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2014 | 180 | 0.090 |
Why?
| | Heart | 1 | 2016 | 620 | 0.090 |
Why?
| | Pulmonary Gas Exchange | 1 | 2012 | 117 | 0.090 |
Why?
| | Sheep, Domestic | 3 | 2019 | 34 | 0.090 |
Why?
| | Signal Transduction | 5 | 2020 | 5168 | 0.090 |
Why?
| | Carbon Isotopes | 1 | 2012 | 143 | 0.090 |
Why?
| | AMP-Activated Protein Kinases | 2 | 2023 | 199 | 0.090 |
Why?
| | Proteolysis | 1 | 2012 | 175 | 0.090 |
Why?
| | Malnutrition | 1 | 2012 | 85 | 0.090 |
Why?
| | Tissue Distribution | 1 | 2012 | 330 | 0.090 |
Why?
| | Hormones | 1 | 2012 | 140 | 0.090 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2012 | 346 | 0.090 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2014 | 270 | 0.080 |
Why?
| | Apoptosis | 1 | 2019 | 2575 | 0.080 |
Why?
| | Taurine | 1 | 2011 | 40 | 0.080 |
Why?
| | Prospective Studies | 1 | 2022 | 7777 | 0.080 |
Why?
| | Ribosomal Protein S6 Kinases | 1 | 2008 | 25 | 0.070 |
Why?
| | Eukaryotic Initiation Factor-4E | 1 | 2008 | 33 | 0.070 |
Why?
| | TOR Serine-Threonine Kinases | 2 | 2009 | 429 | 0.070 |
Why?
| | Somatostatin | 1 | 2008 | 58 | 0.070 |
Why?
| | Galactose | 1 | 2008 | 35 | 0.070 |
Why?
| | Glycine | 2 | 2023 | 185 | 0.070 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2008 | 151 | 0.070 |
Why?
| | Hydrocortisone | 3 | 2016 | 318 | 0.070 |
Why?
| | Acidosis | 1 | 2009 | 102 | 0.070 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 145 | 0.060 |
Why?
| | Lysine | 1 | 2009 | 292 | 0.060 |
Why?
| | Down-Regulation | 3 | 2017 | 641 | 0.060 |
Why?
| | Fetal Diseases | 2 | 2021 | 181 | 0.050 |
Why?
| | Embryo, Mammalian | 2 | 2019 | 236 | 0.050 |
Why?
| | DNA Replication | 1 | 2025 | 240 | 0.050 |
Why?
| | Pyruvates | 1 | 2023 | 24 | 0.050 |
Why?
| | Glutamine | 1 | 2023 | 107 | 0.050 |
Why?
| | Serine | 1 | 2023 | 148 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2019 | 987 | 0.050 |
Why?
| | Mammals | 1 | 2023 | 287 | 0.040 |
Why?
| | Amino Acids, Essential | 1 | 2021 | 13 | 0.040 |
Why?
| | Isoleucine | 1 | 2021 | 15 | 0.040 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2019 | 876 | 0.040 |
Why?
| | Fetal Macrosomia | 1 | 2021 | 63 | 0.040 |
Why?
| | Phenylalanine | 1 | 2021 | 67 | 0.040 |
Why?
| | Valine | 1 | 2021 | 77 | 0.040 |
Why?
| | Pancreatic Diseases | 1 | 2021 | 67 | 0.040 |
Why?
| | Carnitine | 1 | 2021 | 83 | 0.040 |
Why?
| | Mitochondria, Liver | 1 | 2020 | 70 | 0.040 |
Why?
| | Uterine Artery | 1 | 2020 | 75 | 0.040 |
Why?
| | Drug Synergism | 1 | 2020 | 375 | 0.040 |
Why?
| | Glycolysis | 1 | 2021 | 327 | 0.040 |
Why?
| | Transcription Factors | 1 | 2007 | 1712 | 0.040 |
Why?
| | Proton Magnetic Resonance Spectroscopy | 1 | 2019 | 20 | 0.040 |
Why?
| | Glutathione | 1 | 2020 | 362 | 0.040 |
Why?
| | Birth Weight | 1 | 2021 | 515 | 0.040 |
Why?
| | Cell Differentiation | 1 | 2025 | 2006 | 0.030 |
Why?
| | Estrogens | 1 | 2020 | 368 | 0.030 |
Why?
| | Chronic Disease | 2 | 2017 | 1820 | 0.030 |
Why?
| | Diabetes, Gestational | 1 | 2021 | 320 | 0.030 |
Why?
| | Homeostasis | 1 | 2020 | 636 | 0.030 |
Why?
| | Glycogen | 1 | 2016 | 54 | 0.030 |
Why?
| | Umbilical Cord | 1 | 2016 | 87 | 0.030 |
Why?
| | Carbon Radioisotopes | 1 | 2014 | 31 | 0.030 |
Why?
| | Models, Animal | 1 | 2016 | 396 | 0.030 |
Why?
| | Biological Transport | 1 | 2014 | 410 | 0.030 |
Why?
| | Animals, Inbred Strains | 1 | 2012 | 6 | 0.020 |
Why?
| | Fatal Outcome | 1 | 2014 | 309 | 0.020 |
Why?
| | Blood Transfusion | 1 | 2016 | 393 | 0.020 |
Why?
| | Cell Size | 1 | 2012 | 89 | 0.020 |
Why?
| | Glutamic Acid | 1 | 2014 | 256 | 0.020 |
Why?
| | Electrolytes | 1 | 2012 | 56 | 0.020 |
Why?
| | Solutions | 1 | 2012 | 168 | 0.020 |
Why?
| | Transcriptome | 1 | 2019 | 1013 | 0.020 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2012 | 159 | 0.020 |
Why?
| | Prenatal Diagnosis | 1 | 2014 | 190 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1771 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2012 | 200 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2021 | 5212 | 0.020 |
Why?
| | Energy Intake | 1 | 2014 | 513 | 0.020 |
Why?
| | Myocardium | 1 | 2016 | 928 | 0.020 |
Why?
| | Erythrocytes | 1 | 2016 | 707 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2012 | 444 | 0.020 |
Why?
| | Adenylate Kinase | 1 | 2009 | 27 | 0.020 |
Why?
| | Infusions, Parenteral | 1 | 2009 | 43 | 0.020 |
Why?
| | Peptide Chain Initiation, Translational | 1 | 2009 | 44 | 0.020 |
Why?
| | Liver Glycogen | 1 | 2007 | 16 | 0.020 |
Why?
| | Remission Induction | 1 | 2009 | 309 | 0.020 |
Why?
| | Oncogene Protein v-akt | 1 | 2007 | 25 | 0.020 |
Why?
| | Fever | 1 | 2009 | 308 | 0.020 |
Why?
| | Receptor, Insulin | 1 | 2007 | 100 | 0.020 |
Why?
| | Biomarkers | 1 | 2019 | 4190 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2009 | 556 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 2007 | 533 | 0.020 |
Why?
| | Mice | 1 | 2020 | 18108 | 0.010 |
Why?
| | Phosphorylation | 1 | 2007 | 1774 | 0.010 |
Why?
| | Models, Biological | 1 | 2009 | 1828 | 0.010 |
Why?
| | Obesity | 1 | 2011 | 3008 | 0.010 |
Why?
| | Adolescent | 1 | 2014 | 22130 | 0.010 |
Why?
| | Adult | 1 | 2011 | 39391 | 0.000 |
Why?
|
|
Brown's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|